Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
1.750
-0.270 (-13.37%)
At close: Mar 27, 2026, 4:00 PM EDT
1.680
-0.070 (-4.00%)
After-hours: Mar 27, 2026, 7:55 PM EDT
Co-Diagnostics Revenue
Co-Diagnostics had revenue of $145.38K in the quarter ending September 30, 2025, a decrease of -77.32%. This brings the company's revenue in the last twelve months to $507.89K, down -93.06% year-over-year. In the year 2024, Co-Diagnostics had annual revenue of $3.92M, down -42.53%.
Revenue (ttm)
$507.89K
Revenue Growth
-93.06%
P/S Ratio
7.77
Revenue / Employee
$3,848
Employees
132
Market Cap
3.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.92M | -2.90M | -42.53% |
| Dec 31, 2023 | 6.81M | -27.41M | -80.09% |
| Dec 31, 2022 | 34.22M | -63.67M | -65.04% |
| Dec 31, 2021 | 97.89M | 23.33M | 31.30% |
| Dec 31, 2020 | 74.55M | 74.34M | 34,579.90% |
| Dec 31, 2019 | 214.97K | 175.06K | 438.63% |
| Dec 31, 2018 | 39.91K | 32.25K | 420.90% |
| Dec 31, 2017 | 7.66K | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | 10.00K | - | - |
| Dec 31, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AVITA Medical | 71.61M |
| Nuwellis | 8.27M |
| Beyond Air | 6.92M |
| Biomerica | 4.46M |
| Tenon Medical | 3.94M |
| Intelligent Bio Solutions | 3.58M |
| iTonic Holdings | 305.22K |
| Nexalin Technology | 301.65K |
CODX News
- 3 days ago - Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization - PRNewsWire
- 3 days ago - EXCLUSIVE: Co-Diagnostics Ships Diagnostic Tests To India Ahead Of TB Study Launch - Benzinga
- 8 days ago - Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia - PRNewsWire
- 8 days ago - EXCLUSIVE: Co-Diagnostics Expands South Asia Reach, Targets $13 Billion Market Opportunity - Benzinga
- 11 days ago - Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast - PRNewsWire
- 12 days ago - Co-Diagnostics to Present at Medical Korea 2026 - PRNewsWire
- 16 days ago - Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies - PRNewsWire
- 18 days ago - Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements - PRNewsWire